Received Sep 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RVX | ROTAVIRUS (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
the vaccine actually likely saved my life; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of unexpected therapeutic effect in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis. Concurrent medical conditions included asthma. On an unknown date, the patient received RSV vaccine. On an unknown date, an unknown time after receiving RSV vaccine, the patient experienced unexpected therapeutic effect (Verbatim: the vaccine actually likely saved my life). The outcome of the unexpected therapeutic effect was not applicable. Additional Information: GSK Receipt Date: 15-AUG-2025 The patient was asthmatic. It was reported that if you understand the pathology of that disease, it causes scarring of lung tissue over time and repeated flares. The vaccine actually likely saved the patient's life. The patient was back to pre-covid lung status now. The asthmatics were considered high risk, and their chances of permanent damage is high. Plus their age puts them at a high risk. The morbidity is much higher, and the vaccine, in fact, lessons these outcomes.
Asthma